New crystal form and pharmaceutical compositions of (+)-R-zileuton

摘要

A crystalline form of (+)-R-zileuton, which may be used in pharmaceutical applications, is disclosed, characterized by a variety of properties and physical measurements. As well, methods of producing crystalline (+)-R-zileuton, and using it to inhibit 5-lipoxygenase activity in subjects to treat a number of diseases, are also discussed.